Literature DB >> 26253094

Genome-Wide Sequencing for Prenatal Detection of Fetal Single-Gene Disorders.

Ignatia B van den Veyver1, Christine M Eng2.   

Abstract

New sequencing methods capable of rapidly analyzing the genome at increasing resolution have transformed diagnosis of single-gene or oligogenic genetic disorders in pediatric and adult medicine. Targeted tests, consisting of disease-focused multigene panels and diagnostic exome sequencing to interrogate the sequence of the coding regions of nearly all genes, are now clinically offered when there is suspicion for an undiagnosed genetic disorder or cancer in children and adults. Implementation of diagnostic exome and genome sequencing tests on invasively and noninvasively obtained fetal DNA samples for prenatal genetic diagnosis is also being explored. We predict that they will become more widely integrated into prenatal care in the near future. Providers must prepare for the practical, ethical, and societal dilemmas that accompany the capacity to generate and analyze large amounts of genetic information about the fetus during pregnancy.
Copyright © 2015 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26253094      PMCID: PMC4588135          DOI: 10.1101/cshperspect.a023077

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  95 in total

Review 1.  Incidental findings from clinical genome-wide sequencing: a review.

Authors:  Z Lohn; S Adam; P H Birch; J M Friedman
Journal:  J Genet Couns       Date:  2013-05-26       Impact factor: 2.537

Review 2.  Copy number and SNP arrays in clinical diagnostics.

Authors:  Christian P Schaaf; Joanna Wiszniewska; Arthur L Beaudet
Journal:  Annu Rev Genomics Hum Genet       Date:  2011       Impact factor: 8.929

3.  New approaches to molecular diagnosis.

Authors:  Bruce R Korf; Heidi L Rehm
Journal:  JAMA       Date:  2013-04-10       Impact factor: 56.272

4.  Genome sequencing identifies major causes of severe intellectual disability.

Authors:  Christian Gilissen; Jayne Y Hehir-Kwa; Djie Tjwan Thung; Maartje van de Vorst; Bregje W M van Bon; Marjolein H Willemsen; Michael Kwint; Irene M Janssen; Alexander Hoischen; Annette Schenck; Richard Leach; Robert Klein; Rick Tearle; Tan Bo; Rolph Pfundt; Helger G Yntema; Bert B A de Vries; Tjitske Kleefstra; Han G Brunner; Lisenka E L M Vissers; Joris A Veltman
Journal:  Nature       Date:  2014-06-04       Impact factor: 49.962

5.  Personal genome research : what should the participant be told?

Authors:  Amy L McGuire; James R Lupski
Journal:  Trends Genet       Date:  2010-04-08       Impact factor: 11.639

6.  Next-generation sequencing identifies rare variants associated with Noonan syndrome.

Authors:  Peng-Chieh Chen; Jiani Yin; Hui-Wen Yu; Tao Yuan; Minerva Fernandez; Christina K Yung; Quang M Trinh; Vanya D Peltekova; Jeffrey G Reid; Erica Tworog-Dube; Margaret B Morgan; Donna M Muzny; Lincoln Stein; John D McPherson; Amy E Roberts; Richard A Gibbs; Benjamin G Neel; Raju Kucherlapati
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-21       Impact factor: 11.205

7.  FORGE Canada Consortium: outcomes of a 2-year national rare-disease gene-discovery project.

Authors:  Chandree L Beaulieu; Jacek Majewski; Jeremy Schwartzentruber; Mark E Samuels; Bridget A Fernandez; Francois P Bernier; Michael Brudno; Bartha Knoppers; Janet Marcadier; David Dyment; Shelin Adam; Dennis E Bulman; Steve J M Jones; Denise Avard; Minh Thu Nguyen; Francois Rousseau; Christian Marshall; Richard F Wintle; Yaoqing Shen; Stephen W Scherer; Jan M Friedman; Jacques L Michaud; Kym M Boycott
Journal:  Am J Hum Genet       Date:  2014-06-05       Impact factor: 11.025

8.  Deleterious- and disease-allele prevalence in healthy individuals: insights from current predictions, mutation databases, and population-scale resequencing.

Authors:  Yali Xue; Yuan Chen; Qasim Ayub; Ni Huang; Edward V Ball; Matthew Mort; Andrew D Phillips; Katy Shaw; Peter D Stenson; David N Cooper; Chris Tyler-Smith
Journal:  Am J Hum Genet       Date:  2012-12-07       Impact factor: 11.025

9.  The usefulness of whole-exome sequencing in routine clinical practice.

Authors:  Alejandro Iglesias; Kwame Anyane-Yeboa; Julia Wynn; Ashley Wilson; Megan Truitt Cho; Edwin Guzman; Rebecca Sisson; Claire Egan; Wendy K Chung
Journal:  Genet Med       Date:  2014-06-05       Impact factor: 8.822

10.  Obtaining informed consent for clinical tumor and germline exome sequencing of newly diagnosed childhood cancer patients.

Authors:  Sarah Scollon; Katie Bergstrom; Robin A Kerstein; Tao Wang; Susan G Hilsenbeck; Uma Ramamurthy; Richard A Gibbs; Christine M Eng; Murali M Chintagumpala; Stacey L Berg; Laurence B McCullough; Amy L McGuire; Sharon E Plon; D Williams Parsons
Journal:  Genome Med       Date:  2014-09-17       Impact factor: 11.117

View more
  13 in total

Review 1.  Whole-Exome Sequencing and Whole-Genome Sequencing in Critically Ill Neonates Suspected to Have Single-Gene Disorders.

Authors:  Laurie D Smith; Laurel K Willig; Stephen F Kingsmore
Journal:  Cold Spring Harb Perspect Med       Date:  2015-12-18       Impact factor: 6.915

2.  Is preparation a good reason for prenatal genetic testing? Ethical and critical questions.

Authors:  Marsha Michie
Journal:  Birth Defects Res       Date:  2020-03-01       Impact factor: 2.344

3.  VarElect: the phenotype-based variation prioritizer of the GeneCards Suite.

Authors:  Gil Stelzer; Inbar Plaschkes; Danit Oz-Levi; Anna Alkelai; Tsviya Olender; Shahar Zimmerman; Michal Twik; Frida Belinky; Simon Fishilevich; Ron Nudel; Yaron Guan-Golan; David Warshawsky; Dvir Dahary; Asher Kohn; Yaron Mazor; Sergey Kaplan; Tsippi Iny Stein; Hagit N Baris; Noa Rappaport; Marilyn Safran; Doron Lancet
Journal:  BMC Genomics       Date:  2016-06-23       Impact factor: 3.969

Review 4.  Recent advances in prenatal genetic screening and testing.

Authors:  Ignatia B Van den Veyver
Journal:  F1000Res       Date:  2016-10-28

5.  Development of a rapid functional assay that predicts GLUT1 disease severity.

Authors:  Sasha M Zaman; Saul A Mullen; Slavé Petrovski; Snezana Maljevic; Elena V Gazina; A Marie Phillips; Gabriel Davis Jones; Michael S Hildebrand; John Damiano; Stéphane Auvin; Holger Lerche; Yvonne G Weber; Samuel F Berkovic; Ingrid E Scheffer; Christopher A Reid; Steven Petrou
Journal:  Neurol Genet       Date:  2018-12-06

6.  Evaluation of Diagnostic Yield in Fetal Whole-Exome Sequencing: A Report on 45 Consecutive Families.

Authors:  Lior Greenbaum; Ben Pode-Shakked; Shlomit Eisenberg-Barzilai; Michal Dicastro-Keidar; Anat Bar-Ziv; Nurit Goldstein; Haike Reznik-Wolf; Hana Poran; Amihai Rigbi; Ortal Barel; Aida M Bertoli-Avella; Peter Bauer; Miriam Regev; Annick Raas-Rothschild; Elon Pras; Michal Berkenstadt
Journal:  Front Genet       Date:  2019-06-25       Impact factor: 4.599

Review 7.  A Simple Practical Guide to Genomic Diagnostics in a Pediatric Setting.

Authors:  Alan Taylor; Zeinab Alloub; Ahmad Abou Tayoun
Journal:  Genes (Basel)       Date:  2021-05-27       Impact factor: 4.096

Review 8.  Genetic approaches to metabolic bone diseases.

Authors:  Fadil M Hannan; Paul J Newey; Michael P Whyte; Rajesh V Thakker
Journal:  Br J Clin Pharmacol       Date:  2018-11-28       Impact factor: 4.335

9.  Accuracy of in-utero MRI to detect fetal brain abnormalities and prognosticate developmental outcome: postnatal follow-up of the MERIDIAN cohort.

Authors:  Anthony R Hart; Nicholas D Embleton; Michael Bradburn; Daniel J A Connolly; Laura Mandefield; Cara Mooney; Paul D Griffiths
Journal:  Lancet Child Adolesc Health       Date:  2019-11-27

10.  Prenatal exome sequencing in anomalous fetuses: new opportunities and challenges.

Authors:  Neeta L Vora; Bradford Powell; Alicia Brandt; Natasha Strande; Emily Hardisty; Kelly Gilmore; Ann Katherine M Foreman; Kirk Wilhelmsen; Chris Bizon; Jason Reilly; Phil Owen; Cynthia M Powell; Debra Skinner; Christine Rini; Anne D Lyerly; Kim A Boggess; Karen Weck; Jonathan S Berg; James P Evans
Journal:  Genet Med       Date:  2017-05-18       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.